While convenient access to medication sounds appealing, weight loss is a complex medical endeavor
It has not yet been FDA approved, but is showing great promise for weight loss
Retatrutide's additional GIP and glucagon activation pushes weight loss substantially higher while potentially reducing the gastrointestinal side effects that limit semaglutide tolerability for some users
Its important to start slowly, stay hydrated, and monitor for side effects like nausea or low blood sugar
While nausea typically resolved over time, diarrhea (observed in 5% of our cohort) tended to persist when present, though it was manageable in most cases with antidiarrheal agents
If you want to see whether a personalized prescription program is a fit, you can take the free assessment quiz